Literature DB >> 10580059

An analysis of the role of neuraminidase in the receptor-binding activity of influenza B virus: the inhibitory effect of Zanamivir on haemadsorption.

C Luo1, E Nobusawa1, K Nakajima1.   

Abstract

We analysed the role of neuraminidase (NA) on haemadsorption by the haemagglutinin (HA) protein of influenza B virus. The influenza B virus mutant ts-7 has a temperature-sensitive mutation in the NA protein. At high temperature, cells infected with this virus did not exhibit haemadsorption activity, but the addition of bacterial neuraminidase (bNA) restored haemadsorption activity. COS cells transfected with HA cDNAs of B/Kanagawa/73 or B/Lee/40 virus showed no evidence of haemadsorption. However, with the addition of bNA or co- transfection with NA cDNA of the B/Lee/40 virus, haemadsorption was observed. Experiments with point-mutated HA cDNAs of B/Lee/40 virus showed that two N-acetyl glycosylation sites at amino acid residues 160 and 217 were responsible for the inability of the HA protein to adsorb to erythrocytes. These results indicated that haemadsorption by the HA protein of influenza B virus required the involvement of NA. Because the NA inhibitor Zanamivir was reported not to penetrate cells, we investigated the action of this inhibitor and found that Zanamivir inhibited haemadsorption on MDCK cells infected with B/Kanagawa/73 or B/Lee/40 virus. After removing Zanamivir by washing, the addition of bNA restored the haemadsorption activity on the infected cells. Scanning electron microscopy indicated that at 0.4 microM Zanamivir, HA protein did not adsorb to erythrocytes but retained the ability to aggregate virions. However, at 4 microM Zanamivir, distinct virion formation could not be observed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580059     DOI: 10.1099/0022-1317-80-11-2969

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Generation of influenza A viruses with chimeric (type A/B) hemagglutinins.

Authors:  Taisuke Horimoto; Ayato Takada; Kiyoko Iwatsuki-Horimoto; Masato Hatta; Hideo Goto; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.

Authors:  M Porotto; O Greengard; N Poltoratskaia; M A Horga; A Moscona
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Shift in oligosaccharide specificities of hemagglutinin and neuraminidase of influenza B viruses resistant to neuraminidase inhibitors.

Authors:  Larisa Mochalova; Rick Bright; Xiyan Xu; Elena Korchagina; Alexander Chinarev; Nicolai Bovin; Alexander Klimov
Journal:  Glycoconj J       Date:  2010-03-02       Impact factor: 2.916

4.  Influence of acylation sites of influenza B virus hemagglutinin on fusion pore formation and dilation.

Authors:  Makoto Ujike; Katsuhisa Nakajima; Eri Nobusawa
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

5.  Novel antiviral activity of neuraminidase inhibitors against an avian influenza a virus.

Authors:  Hiroshi Ushirogawa; Masanobu Ohuchi
Journal:  Virol J       Date:  2011-08-19       Impact factor: 4.099

6.  Identification of traditional medicinal plant extracts with novel anti-influenza activity.

Authors:  Dhivya Rajasekaran; Enzo A Palombo; Tiong Chia Yeo; Diana Lim Siok Ley; Chu Lee Tu; Francois Malherbe; Lara Grollo
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

7.  Rescue of a H3N2 influenza virus containing a deficient neuraminidase protein by a hemagglutinin with a low receptor-binding affinity.

Authors:  Mathilde Richard; Alexandra Erny; Bertrand Caré; Aurélien Traversier; Mendy Barthélémy; Alan Hay; Yi Pu Lin; Olivier Ferraris; Bruno Lina
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.